CALCA and COVID-19: Since the beginning of the COVID-19 pandemic, multiple observational studies and meta-analyses have been done to look into the utility of serum PCT level as a biomarker of clinical deterioration among COVID-19 patients and have shown encouraging results with various optimal PCT cut-points suggested [9–11].